With AI, researchers predict the location of virtually any protein within a human cell
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
Medicine
Study shows vision-language models can’t handle queries with negation words
Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.
Q&A: A roadmap for revolutionizing health care through data-driven innovation
A new book coauthored by MIT’s Dimitris Bertsimas explores how analytics is driving decisions and outcomes in health care.
Making AI models more trustworthy for high-stakes settings
A new method helps convey uncertainty more precisely, which could give researchers and medical clinicians better information to make decisions.
Novel method detects microbial contamination in cell cultures
Ultraviolet light “fingerprints” on cell cultures and machine learning can provide a definitive yes/no contamination assessment within 30 minutes.
Could LLMs help design our next medicines and materials?
A new method lets users ask, in plain language, for a new molecule with certain properties, and receive a detailed description of how to synthesize it.
MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Can deep learning transform heart failure prevention?
A deep neural network called CHAIS may soon replace invasive procedures like catheterization as the new gold standard for monitoring heart health.
Toward video generative models of the molecular world
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.
MIT researchers introduce Boltz-1, a fully open-source model for predicting biomolecular structures
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.